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Abstract
A gallbladder polyp is an elevation of the gallbladder 
mucosa that protrudes into the gallbladder lumen. 
Gallbladder polyps have an estimated prevalence in adults 
of between 0.3%-12.3%. However, only 5% of polyps are 
considered to be “true” gallbladder polyps, meaning that 
they are malignant or have malignant potential. The main 
radiological modality used for diagnosing and surveilling 
gallbladder polyps is transabdominal ultrasonography. 
However, evidence shows that other modalities such as 
endoscopic ultrasound may improve diagnostic accuracy. 
These are discussed in turn during the course of this 
review. Current guidelines recommend cholecystectomy 
for gallbladder polyps sized 10 mm and greater, although 
this threshold is lowered when other risk factors are 
identified. The evidence behind this practice is relatively 
low quality. This review identifies current gaps in the 
available evidence and highlights the necessity for further 
research to enable better decision making regarding 
which patients should undergo cholecystectomy, and/or 
radiological follow-up.
Key words: Gallbladder polyps; Gallbladder cancer; True 
polyps; Pseudo polyps
© The Author(s) 2018. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Evidence for the optimum management of 
gallbladder polyps is lacking. The main imaging modality 
used for diagnosis and follow-up is transabdominal ultra-
sound, but some studies suggest improved accuracy with 
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endoscopic ultrasound. Other imaging modalities lack 
evidence. Surgical management involves cholecystectomy 
and the general consensus is that polyps 10 mm and 
greater should undergo surgery. However, this is an arbi-
trary cut-off and high-quality evidence to support this 
is lacking. Lowering the threshold for cholecystectomy 
when patients have additional risk factors for gallbladder 
malignancy may improve the cancer detection rate in 
polyps smaller than 10 mm, but again, the evidence 
behind this is lacking.
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24(26): 2844-2852  Available from: URL: http://www.wjgnet.
com/1007-9327/full/v24/i26/2844.htm  DOI: http://dx.doi.
org/10.3748/wjg.v24.i26.2844
INTRODUCTION
A gallbladder polyp is an elevation of the gallbladder 
mucosa that protrudes into the gallbladder lumen[1,2]. 
Gallbladder polyps have an estimated prevalence of 
approximately 5% in the global population, but only 
5% of these are considered to be “true” gallbladder 
polyps[3,4]. The majority of gallbladder polyps are de­
tected incidentally on radiological imaging or histological 
examination after cholecystectomy. However, a small 
number of patients with gallbladder polyps may be 
symptomatic and present with acute cholecystitis due 
to the polyp obstructing the cystic duct, or cholangitis 
due to fragments of the polyp breaking off and travelling 
down into in the bile duct[2,5]. The majority of gallbladder 
polyps are classified as “pseudo”-polyps, as displayed in 
Figure 1. “Pseudo”­polyps have no malignant potential 
and do not require any follow­up or intervention, whereas 
“true” gallbladder polyps, which include adenocarcinomas 
or adenomas require surgical removal[2]. Although ade­
nomas are benign, they have malignant potential and 
there is some evidence to suggest they may follow the 
adenoma­carcinoma sequence as seen in colorectal 
cancer[6,7].
Gallbladder cancer is the 20th most common cancer 
in the world and there are an estimated 178100 new 
cases diagnosed each year[8]. The highest incidences of 
gallbladder cancer are seen in South America and Asia, 
whilst lower incidences are seen in developed regions 
such as North America and the United Kingdom[9]. For 
example, the incidence of gallbladder cancer in Chile 
and Bolivia is 12.8 and 10.9 per 100000 population 
respectively, whereas in the United Kingdom and 
North America the incidence is 1.6 and 1.5 per 100000 
people[9,10]. The staging of gallbladder cancer as per the 
American Joint Committee on Cancer 8th edition, ranges 
from stage 0 to stage 4b. Stage 0 describes carcinoma 
in­situ when the cancer involves the mucosa only as 
seen in early polyp cancers, while stage 4b indicates 
lymph node involvement of 4 or more lymph nodes 
(N2 disease) or the presence of metastatic disease[11]. 
Survival in gallbladder cancer patients varies significantly 
from an 80% 5­year survival in those with in­situ 
disease, declining to only 8% when lymph nodes are 
involved, and 2% for patients with stage 4b disease[11]. 
These figures demonstrate the importance of identifying 
malignant and pre­malignant polyps to enable early 
treatment to prevent cancer spread or development of 
malignancy.
It should be noted that once detected, surgical 
removal of all gallbladder polyps is not appropriate, 
given that the majority of polyps are “pseudo”­polyps 
with no malignant potential and there is a significant 
risk associated with surgery. In patients with “true” 
gallbladder polyps, laparoscopic cholecystectomy is the 
surgical option preferred, although in patients with larger 
polyps, open cholecystectomy is recommended[12,13]. 
The risks associated with surgery include damage to 
intra­abdominal structures during port insertion, bile 
duct injury (between 0.3% and 1%) and bile leak[14,15]. 
Furthermore, surgical intervention to repair a bile duct 
injury and endoscopic retrograde cholangio­pancrea­
tography (ERCP) to manage a bile leak are associated 
with significant mortality, cholangitis, biliary cirrhosis, 
pancreatitis, perforation and haemorrhage[16,17].
This review discusses the current evidence that 
exists regarding the management of gallbladder polyps. 
Given the low incidence of true polyps within all gall­
bladder polyps identified, coupled with the high morta-
lity associated with gallbladder cancer and the risk of 
complications associated with cholecystectomy, it is 
essential to differentiate between “pseudo”­ polyps and 
true polyps to enable appropriate management. The use 
of imaging modalities assists with the decision­making 
process and this review discusses the benefits and short-
comings of the imaging modalities used for identifying 
and following up gallbladder polyps. 
THE ROLE OF DIFFERENT IMAGING 
MODALITIES IN GALLBLADDER POLYP 
DIAGNOSIS
Radiological imaging plays the main role in the diagnosis 
and decision making for the management of gallbladder 
polyps. The ideal imaging modalities should have three 
key features. Firstly, they should be able to accurately 
diagnose polyps and differentiate them from gallstones, 
sludge, or folds of the gallbladder mucosa. Secondly, 
“true” polyps need to be differentiated from “pseudo”­ 
polyps, as the latter are benign with no malignant po­
tential and therefore do not require any intervention or 
follow­up. Thirdly, the size of polyps need to be measured 
accurately as this is currently the most important factor 
which determines if patients should undergo chole­
cystectomy, radiological follow up or cease to be followed 
up. Given that some patients with gallbladder polyps will 
require follow­up for many years, it is also important that 
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the imaging modality is acceptable to patients and incurs 
minimal radiation exposure.
Accurate imaging will prevent unnecessary surgery 
and ensure true polyps which do not fall into the size 
criteria for surgical removal category are identified during 
follow­up. The benefits and shortcomings of different 
imaging modalities are discussed below. The main mo­
dalities discussed include ultrasonography, computed 
tomography and magnetic resonance imaging.
Transabdominal ultrasonography
Trans abdominal ultrasound (TAUS), encompasses con­
ventional ultrasound (CUS), high­resolution ultrasound 
(HRUS), three­dimensional ultrasound and contrast 
enhanced ultrasound (CEUS). CUS and HRUS are easily 
accessible, cheap, non­invasive tests[18] and are the most 
widely used modalities for diagnosing and following up 
gallbladder polyps. However, other studies have been 
performed to assess the effectiveness of the other forms 
of ultrasonography mentioned above[18,19].
Ultrasonography is operator dependent and re­
sults can be limited by increased body mass index, 
in particular truncal obesity[20]. Polyp echogenicity is 
examined to distinguish between “true” polyps and 
“pseudo”- polyps and the presence of a fixed lesion helps 
to distinguish between polyps and gallstones. However, 
in some cases gallstones may be impacted in the gall­
bladder wall and be incorrectly labelled as a polyp[2]. 
Features that suggest the presence of a “pseudo”­ polyp 
include a “comet tail” which arises posterior to the lesion 
but this is not identifiable in all “pseudo”- polyps[21].
CUS uses a low­frequency transducer between 2 and 
5MHz but despite this has demonstrated good specificity 
(71%­98%) and sensitivity (50%­90%) for diagnosing 
all types of gallbladder polyps[22]. In the same systematic 
review, CUS had a sensitivity of 47%-67% and specificity 
of 36­100% for diagnosing malignancy[22] and in polyps 
10mm or greater in size, the sensitivity and specificity for 
identifying malignancy was 78%­100% and 52%­87%, 
respectively[22]. 
However, shortcomings in CUS have been reported, 
for example in a single study by French et al[23] which 
compared histopathology reports from cholecystectomy 
specimens with findings from the CUS report found 
that imaging only identified 50% of polyps. This group 
concluded that CUS should not be used for following up 
gallbladder polyps[23] . 
HRUS operates at a higher frequency than CUS (5­7 
MHz) but a lower frequency than endoscopic ultrasound 
(EUS) (5­12 MHz) and therefore theoretically has a 
better diagnostic accuracy than CUS but is less accurate 
than EUS[24]. It does however have the benefit over EUS, 
in that it is a non­invasive procedure. Kim et al[24] demon­
strated that HRUS is more accurate than CUS at staging 
the T­stage of gallbladder cancer and was more accurate 
for identifying hypoechoic foci in neoplastic polyps which 
has previously been shown to be a strong predictive 
factor for neoplastic gallbladder polyps[24,25]. More studies 
however are required which compare the sensitivity and 
specificity of CUS and HRUS.
One study has compared HRUS, endoscopic ultra­
sound (EUS), and computed tomography (CT) in diag­
nosing and staging gallbladder polyps in 144 patients 
who all had a polyp greater than 10 mm in size[26]. 
Diagnostic sensitivities for malignancy were highest in 
HRUS, compared to the other two modalities and spe­
cificity was the same when using EUS and HRUS[26]. The 
drawback from this study however is that the applicability 
of this technique to smaller gallbladder polyps remains 
unknown and polyps of less than 10 mm are diagnos­
tically most difficult group to assess. Furthermore, HRUS 
was not compared to CUS, which is currently the most 
commonly used imaging modality. 
3D­US is an emerging modality which eliminates the 
operator dependency seen in 2­dimensional CUS. Re­
search for this imaging modality is minimal but a study of 
80 patients with gallbladder polyps found that there was 
agreement in the diagnosis in 89% of cases when both 
techniques were applied[27]. This study however found 
that 3D-US did have difficulty detecting polyps less than 
4mm, but it is predicted that as technology continues to 
evolve this issue will decline in future[27]. Current research 
therefore does not support the routine use of 3D­US for 
evaluating gallbladder polyps.
Several small studies have looked at the use of con­
trast media to improve the diagnostic accuracy of CUS. 
Contrast aids radiologists to differentiate normal from 
abnormal conditions. Numata et al[28] used galactose 
palmitic acid contrast injection to assess 35 polyps which 
were larger than 10 mm in size. Using the criteria of 
tumour enhancement and tortuous type tumour vessels, 
this technique had 91% accuracy at identifying mali­
gnancy. The downside to this study however, is that it did 
not compare contrast­enhanced ultrasonography with 
CUS[28]. Zheng et al[29] did compare the two modalities 
in a study of 116 patients with gallbladder polyps, and 
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Figure 1  Spider diagram showing the classification of gallbladder polyps.
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group of patients[35]. Lou et al[36] assessed the accuracy of 
CT biliary cystoscopy in 32 patients and found that CUS 
accurately detected polyps in 96.9% of cases compared 
to 93.8% for CT. 
This evidence would suggest that CT imaging is best 
used in staging larger, suspicious malignant polyps, 
rather than for diagnostic purposes and follow­up, due 
to lack of superiority to CUS demonstrated in studies to 
date. 
Magnetic resonance imaging 
Minimal research has been performed looking at the 
role of MRI in differentiating between benign and malig­
nant gallbladder polyps. In a small study, Irie at al[37] 
demonstrated in 10 benign polyps and 13 malignant 
polyps that the ADC values of the malignant lesions were 
significantly lower than that seen in the benign lesions. 
They concluded that diffusion­weighted MR imaging may 
play a role in diagnosing benign and malignant polyps[37]. 
However, further research is warranted to establish if 
MRI can improve the accuracy of diagnosing gallbladder 
polyps.
Other imaging modalities
Other imaging modalities have been considered in 
small single studies. One study has shown that positive 
emission tomography can differentiate between benign 
and malignant disease but more research is needed[2]. 
Results from a study examining the role of percutaneous 
transhepatic cholecystoscopy were promising but this 
is an invasive procedure with significant risk and is 
difficult for patients to tolerate[2]. Finally, intravenous 
cholecystography has shown to be of no benefit to date, 
compared with current imaging modalities[18].
After studying the evidence, TAUS and in particular 
CUS and HRUS would appear to be the most appropriate 
imaging modality for detecting gallbladder polyps. Al­
though some studies looking at the role of other forms 
of ultrasonography in managing gallbladder polyps 
appear promising, there is still not enough evidence 
to introduce these modalities into routine practice for 
the management of gallbladder polyps. Evidence for 
smaller gallbladder polyps is of particularly low quality. 
In cases of clear uncertainty however, additional imaging 
modalities may be deployed to help the clinician in their 
decision­making process. The role of CT is evident in 
staging gallbladder cancer but due to a lack of high­
quality studies examining a role in gallbladder polyps and 
the high radiation exposure associated with this imaging, 
it is not appropriate for either the diagnosis or follow­up 
of gallbladder polyps.
FACTORS INFLUENCING THE 
MANAGEMENT OF GALLBLADDER 
POLYPS
Polyp size 
Studies have shown that malignant polyps in general 
found that CEUS was useful for improving diagnostic 
accuracy in polyps greater than 10 mm, but not less than 
10 mm in size.
Endoscopic ultrasound
EUS works at a higher frequency as described above 
and enables the transducer to be in closer proximity 
to the target tissue therefore, hypothetically improving 
diagnostic accuracy[24]. It is however, an invasive exam­
ination associated with a small risk of bleeding and upper 
gastrointestinal perforation and presents a higher risk of 
complications than all forms of TAUS[30]. 
A systematic review has found EUS to have a greater 
sensitivity (67%­86%) and specificity (84%­91%) for 
diagnosing malignancy in polyps than CUS[22]. A single 
study by Sugiyama et al[31] compared EUS and CUS in 58 
patients who had undergone cholecystectomy. All polyps 
were 20 mm or less in size, and EUS was more accurate 
at differentiating between true and “pseudo”­ polyps 
than CUS (97% vs 76%). Cheon et al[32] however, found 
that although EUS was more successful at identifying 
true polyps in those with diameters of 11 mm and 
greater (83% vs 64%), there was not the same success 
in polyps of diameter 10 mm and less (80% vs 72%). 
Therefore, this imaging technique may play a role in 
decreasing the number of unnecessary cholecystectomies 
in larger gallbladder polyps, but more research needs to 
be done investigating its role in smaller polyps, for which 
the management is most controversial.
Two studies have been performed looking at the 
role of contrast­ enhanced EUS (CE­EUS) in diagnosing 
gallbladder polyps. Park studied 34 patients who had a 
cholecystectomy for gallbladder polyps and found that 
CE­EUS when attempting to distinguish adenomatous 
polyps from cholesterol polyps had a sensitivity of 75% 
and specificity of 66.6%. Unfortunately, in this study CE-
EUS was not compared to any other imaging modality. 
Choi et al[33] however compared EUS with CE­EUS and 
found that diagnostic accuracy was slightly improved 
with the latter.
Other methods including the use of real time colour 
Doppler flow EUS has been used to try and improve the 
diagnostic accuracy of EUS. Kim et al[34] found that the 
presence of a strong colour Doppler flow in a study 115 
patients who underwent cholecystectomy for gallbladder 
polyps may help predict the presence of neoplastic polyps 
and therefore further research is warranted.
Computed tomography 
CT imaging is widely used in the staging of gallbladder 
adenocarcinoma[2]. However, some research has been 
performed to assess if it may also play a role in diffe­
rentiating between true and “pseudo”­ polyps and for 
long­term surveillance[35]. The accuracy of CT imaging 
was assessed in 31 patients with polypoid lesions of 
the gallbladder of 3cm or less. The CT diagnosis was 
accurate in 87% of cases however, only 5 polyps were 
less than 11 mm and therefore this study provides us 
with limited evidence regarding the role of CT in this 
McCain RS et al . Management of gallbladder polyps
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tend to be larger than benign polyps[5,22]. Kwon et al[5] 
reported in their study of 291 patients that malignant 
polyps had a mean size of 27.97+/­2.46 mm compared 
to 8.56+/­0.36 mm in the benign group. Currently, the 
polyp size on radiological imaging is the biggest contri­
buting factor to the management plan for gallbladder 
polyps. Multiple retrospective studies have found the risk 
of malignancy rises sharply from 10 mm and upwards, 
and the general consensus is that patients with polyps 
of 10 mm or greater should be treated with chole­
cystectomy[19,22,38]. Although this is the accepted practice, 
evidence for this recommendation lacks quality. The most 
up­to­date guidelines published by the European Society 
of Gastrointestinal and Abdominal Radiology (ESGAR) 
support this approach but two recent systematic re­
views demonstrate that although the majority of 
malignant polyps are over 10 mm in diameter, there 
are a significant number of both malignant polyps or 
polyps with malignant potential under this sizing thresh­
old[19,22,38].
Babu et al[22] performed a systematic review which 
included 43 studies, of which 20 provided information 
on the size and histology of 2347 polyps. Of these, 
356 were classified as true polyps, of which 228 were 
malignant ­ and 29 of these were between 5­10 mm 
but none below the 5 mm size. Bhatt et al[38] in their 
systematic review also demonstrated that there were a 
significant number of malignant polyps under 10 mm in 
size but the probability of malignancy when a polyp was 
4.15 mm or smaller was approximately zero. These two 
large studies demonstrate that although the majority 
of true polyps are over 10 mm there are a significant 
number of true polyps under this cut off which will be 
missed if cholecystectomy is only performed for polyps 
greater than 10 mm. 
Several authors have suggested a change in this cut 
off with some suggesting polyps of 6 mm and larger 
should undergo cholecystectomy whilst others have felt 
that the cut off should be increased to 12mm[39,40]. The 
argument for lowering the threshold carries more weight, 
as demonstrated by the findings in the systematic reviews 
discussed above. The counter­argument of lowering the 
threshold is that by offering cholecystectomy to those 
patients with polyps below 10 mm, a greater number of 
patients may be put through an unnecessary operation 
associated with significant risk of complications. It 
has therefore been proposed that polyps under 10 
mm should undergo surveillance, based on their size 
unless significant risk factors are present in which case 
cholecystectomy should be offered[19].
Surveillance
Polyp surveillance aims to provide a safety net for those 
patients with true polyps that cannot be differentiated 
from “pseudo”­ polyps on radiological investigations and 
are under 10 mm in diameter. It is hypothesised that 
“true” polyps will undergo faster growth, and by careful 
follow-up these can be identified early and removed[22]. 
Guidelines state that polyps which reach 10 mm in size 
or increase in size by 2 mm at follow up transabdominal 
ultrasonography are recommended to be removed 
surgically[19]. However, evidence to support this practice 
is lacking.
There is no consensus on the size of polyps that 
require follow up, or the frequency or duration of follow 
up. The most recent set of guidelines published by 
ESGAR states that patients with polyps of 6­9 mm 
should be followed up more extensively than patients 
with polyps of less than 6 mm[19]. Several studies support 
6 mm as a lower limit cut­off for less extensive follow 
up, but go a step further by suggesting the cessation of 
follow up in polyps less than 6 mm[41,42]. However, this 
has been contradicted by multiple studies which have 
found true polyps to be less than 6 mm in size and a 
single case report that has shown that a 5 mm polyp 
transformed into a 20 mm carcinoma over a period of 
two years[22,38,43]. The evidence would suggest that all 
polyps between 4­10 mm should be followed up equally 
as although the risk reduces with size, there is still a 
significant number of true polyps between 4 mm and 
6mm. Although no malignant polyps have been shown 
to be below 4 mm there is still a risk of adenomas and 
these polyps therefore would still require follow up but on 
a less frequent basis[22].
The recommended follow up for patients with 
gallbladder polyps depends on the size of the polyps 
and the presence of risk factors for malignancy, but 
opinions differ and the evidence base informing these 
guidelines is relatively limited. For example, Babu et 
al[22] recommend that the follow up of polyps 5­10 mm 
should be two scans at six month intervals and following 
this the surveillance plan should be tailored for individual 
patients. The ESGAR group recommend that in polyps of 
6­9 mm, after two initial six monthly scans there should 
be yearly scans up to 5 years. However, in polyps under 
6 mm there should be imaging at 1, 3 and 5 years but 
if he patient has risk factors for malignancy there should 
be more extensive follow­up as those seen for polyps of 
6­9 mm with no risk factors[22]. 
Follow up imaging may have a limited benefit as 
only a small number of polyps actually change in size 
during follow up. Babu et al[22] identified 10 studies which 
looked at the follow up of gallbladder polyps between six 
months and seven years. They found that only 7.6% of 
polyps increased in size and Bhatt et al[38] also found that 
that 93% of polyps did not change in size during follow 
up. Neither study stated if growth was more likely to be 
seen in in pseudo or true polyps and this was supported 
in a third systematic review[44]. Although there is a lack 
of evidence comparing growth patterns between pseudo­
polyps and true polyps, small individual studies have 
shown that both can undergo sudden growth[2].
RISK FACTORS FOR GALLBLADDER 
POLYP MALIGNANCY
As discussed above the main determining factor for 
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gallbladder malignancy is the presence of a polyp 
greater than 10 mm in size. However, not all polyps 
under 10 mm are benign and therefore it is important 
to identify risk factors to enable the clinician to have a 
higher suspicion for malignancy and therefore perform 
cholecystectomy below the 10 mm threshold. These 
potential risk factors are discussed below and sum­
marised in Table 1.
Number of polyps
Evidence is mixed on whether solitary polyps are more 
likely to be malignant compared to the presence of 
multiple polyps. In a systematic review by Bhatt et al[38], 
the probability of malignancy in a polyp under 10 mm if it 
was solitary was 4.3% higher compared to when multiple 
polyps were present. The authors did not deem this to 
incur a high enough risk to suggest cholecystectomy in 
all patients with a solitary polyp under 10mm. Perhaps 
this is the most useful study as the authors look at the 
risk exclusively in the 5­9 mm group and it is this cohort 
in which the evidence is weakest[38]. A study by Kwon et 
al[5] also found that malignant polyps were more likely to 
be solitary (P = 0.02), but this study only patients who 
had gallbladder polyps greater than 10 mm. Several 
other studies however have demonstrated no association 
between a solitary polyp and malignancy. For example, 
Park et al[39] in a study of 689 patients found that 60% of 
benign polyps were solitary and 76% of malignant polyps 
were benign and this was not significantly different (P = 
0.11).
Although the probability of malignancy is not high 
enough to recommend cholecystectomy in all solitary 
polyps, the presence of a solitary polyp should be 
considered in combination with other risk factors for 
malignancy as discussed below.
Sessile morphology
Single studies such as that performed by Kwon et al[5] 
have demonstrated that patients with gallbladder polyps 
of sessile morphology have a higher risk of malignancy 
compared to those with pedunculated polyps (OR: 7.70; 
95%CI: 2.48­23.95). In the systematic review by Bhatt 
et al[38], malignant polyps under 10 mm were also 
more likely to be sessile in nature and the probability 
of malignancy was 13.9% in these patients but chole­
cystectomy was not recommended. However, if there 
was a solitary sessile polyp, the probability of malignancy 
was 24.8% and cholecystectomy was recommended[38]. 
Although Bhatt et al[38] do not recommend cholecys­
tectomy based on sessile morphology alone, the most 
recent guidelines by the ESGAR group use the strength 
of this evidence to recommend cholecystectomy for all 
sessile polyps under between 6 mm and 9 mm. 
Age
The risk of most cancers increases with age and a similar 
pattern is seen for gallbladder cancer. Multiple case 
series support this but the cut off for an increased risk of 
malignancy varies significantly between 50 and 65 years 
old[13,38,39,45]. For example, Park et al[39] identified age 57 
years and older as a risk factor for malignancy, but in 
this study one patient who was only 37 years old had 
a malignant polyp of 10 mm and the one patient who 
had a malignant polyp under 10 mm in size was only 50 
years old. Furthermore, Sarkut et al[46] found that there 
was an increased likelihood of malignancy in patients 
aged 50 and over, but again this was not exclusive as one 
patient under 50 had a malignant polyp. The only study 
to date that looks at the contribution of age to risk of 
malignancy in polyps solely under 10 mm was performed 
by Bhatt et al[38]. They found that when the polyp was 
less than 10 mm and the patient was over 50 that the 
probability of malignancy was 20.7%, and therefore 
cholecystectomy was recommended[38]. The ESGE group 
used this evidence to conclude that if patients are aged 
50 and have polyps of 6­9 mm they should undergo 
cholecystectomy[19]. 
Presence of gallstones
The evidence considering the impact of concurrent 
gallstones and the risk of malignancy in gallbladder 
polyps varies significantly and is of relatively low quality. 
Aldouri et al[47] found that if gallstones were present 
there was an increased risk of malignancy (HR: 3.2; 
Risk factor Direction of association Strength of association Related notable findings Key references
Age Positive Probability of malignancy was 20.7% in those 
patients older than 50
This systematic review studied polyps less 
than 10 mm only
[38]
Sessile 
morphology
Positive Probability of malignancy was 13.9% in 
sessile compared to pedunculated polyps
This systematic review studied polyps less 
than 10 mm only
[38]
Presence of 
gallstones
Inconclusive Aldouri et al[47] found increased risk of 
malignancy with gallstones (HR = 3.2, 
95%CI: 1.42-7.22) but Park et al[39] found no 
difference (P = 0.27)
There is no strong evidence to suggest there 
is a definite association
[39,47] 
Indian Ethnicity Positive HR = 12.92 (95%CI: 3.77-44.29)
This shows a significant HR but the width of 
the CI’s are noted.
This is the only study to compare risk 
between Indian ethnicity and Caucasian race
[47]
Primary sclerosing 
cholangitis
Positive 40%-60% of polyps in patients with PSC 
were malignant
33% of those with benign polyps had 
associated dysplasia
[56]
Table 1  Summary of evidence for association between potential risk factors and malignant gallbladder polyps
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95%CI: 1.42­7.22) but Park et al[39] found that there 
was no association between the presence of gallstones 
and malignancy (P = 0.27). In those patients with 
symptoms due to gallstones, cholecystectomy is already 
recommended and therefore the decision­making 
process is simple. However, the evidence is not strong 
enough to suggest cholecystectomy should be performed 
in all cases with dual pathology.
Ethnicity
As discussed earlier, gallbladder cancer incidence varies 
significantly between countries. A study by Aldouri et 
al[47] carried out in the United Kingdom demonstrated 
that in 5391 patients who underwent cholecystectomy, 
the risk of malignancy was almost 13 times higher in the 
Indian population compared to the Caucasian population 
(HR: 12.92; 95%CI: 3.77­44.29). This is the only study 
to date which compares risk between different ethnic 
groups, however the ESGAR felt the evidence was so 
compelling that their guidelines state that in patients 
of Indian ethnicity and a polyp between 6­9 mm they 
should undergo cholecystectomy[19]. Further research 
needs to be performed comparing other ethnic groups 
to determine if there should be a lower threshold for 
cholecystectomy in different ethnicities.
Primary sclerosing cholangitis
Primary sclerosing cholangitis (PSC) is a recognised 
risk factor for a gallbladder polyp malignancy, and chole­
cystectomy is currently recommended in these patients 
who have a gallbladder polyp irrespective of the polyp 
size[48]. The largest study to date including 286 PSC 
patients, found that in 18 patients with a gallbladder 
polyp, 10 had a malignancy in polyps as small as 5 mm 
whilst in 9 patients who had no mass lesion they still had 
dysplasia of the gallbladder[49]. Furthermore, in a case 
series of 4 patients with PSC and gallbladder polyps, 
all were shown to have malignant disease including in 
two polyps under 10 mm in size[50]. Other evidence is 
less compelling, including a study by Eaton et al[51] who 
found that in 14 patients with PSC and polyps only two 
were malignant. This group concluded that polyps under 
8 mm were less likely to be malignant and in this group 
and follow up should be applied. Given the presence of 
research such as this further research would be justified. 
The difficulty will be recruiting enough patients with both 
pathologies.
Tumour markers
Limited research has been performed to assess if there is 
a role for tumour markers in the pre­operative evaluation 
of gallbladder polyps. The two markers focused on 
to date has been CEA and CA19­9 but no correlation 
between malignancy and elevated markers has been 
found. In a case series of 291 patients, Kwon et al[5] 
found no difference in pre­operative CEA or CA19­9 
levels in the benign or malignant groups. Indeed, the 
CEA level was elevated in more benign cases (5.7%) 
than malignant cases (2.9%). When comparing the 
CA19­9 levels, there were 4.9% of benign group who 
had a raised level and 8.6% of malignant group had a 
raised level[5]. There is no sufficient evidence to show 
that tumour markers will assist in the decision­making 
process for gallbladder polyps.
Genetic risk factors 
To our knowledge, no research has studied genetic risk 
factors for gallbladder polyps, despite multiple studies 
having investigated genetic contributions to gallbladder 
cancer. For example, studies from Shanghai and Sweden 
have noted significantly increased risks of gallbladder 
cancer in patients with a family history of gallbladder 
cancer[52,53]. It has also been shown in a recent review 
that approximately one quarter of cases diagnosed 
in a Utah cohort study were familial[54]. However, the 
difficulty with evaluating family history as a proxy for 
genetic factors is that it may also reflect exposure to 
similar environmental exposures. A recent review has 
highlighted the paucity of research on specific genetic 
polymorphisms with respect to gallbladder cancer risk, 
and extrapolated some biologically plausible hypotheses 
from gallstone aetiology[54­56]. Overall, there is only low 
quality evidence for genetic predisposition to gallbladder 
cancer, and no studies have been conducted for gall­
bladder polyps. Robust, genome­wide association studies 
are required to confirm or deny any potential asso­
ciations.
CONCLUSION
The gaps in the available evidence to support the current 
guidelines on the management of gallbladder polyps 
are outlined above. TAUS is the current mainstay for 
radiological investigation of gallbladder polyps. EUS 
and HRUS have shown some promise as an adjunct 
to TAUS but more work is required to assess the exact 
role and the category of polyps that they may provide 
diagnostic accuracy. Although polyps of 10 mm and 
greater are more likely to be true polyps, this cut­off 
will miss a significant number of true polyps below this 
threshold and cholecystectomy will also be performed 
unnecessarily for pseudopolyps when they are greater 
than 10 mm. The factoring in of the risk factors discussed 
above to lower the threshold for cholecystectomy will 
no doubt decrease the number of missed true polyps 
in the under 10 mm category but cholecystectomy will 
also be performed when it is not required. No research 
has been performed to assess the impact of following 
these guidelines and therefore larger retrospective and 
prospective case series need to be performed to assess 
the success of managing gallbladder polyps as per the 
current guidelines.
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